Delivery Order 15JPSS22D00000056-15DDST25F00000054
Award Date 10/1/25
Potential Completion Date 9/30/26
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20001, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Drug Enforcement Administration (DEA) awarded a $25,000 firm fixed-price delivery order for shipping services to Federal Express Corporation (FedEx) on October 1, 2025, with an ultimate completion date of September 30, 2026. The contract is performed in Washington, DC and carries no set-aside designation, indicating FedEx competed on a full and open basis. This delivery order is issued under the Next Generation Delivery Services 2 (NGDS 2) Indefinite Delivery/Indefinite Quantity (IDIQ)...
- Federal Express Corporation (FedEx) was awarded a delivery order valued at $45,000 by the Drug Enforcement Administration (DEA) for small package delivery services in Washington, DC, effective October 1, 2025, through September 30, 2026. This firm-fixed-price delivery order was issued without a set-aside designation, indicating full and open competition. The award is issued under the Next Generation Delivery Services 2 (NGDS 2) Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle,...
- The Drug Enforcement Administration awarded a delivery order for small package delivery services to Federal Express Corporation (FedEx) on October 1, 2025, with an ultimate completion date of September 30, 2026. This firm fixed-price delivery order, valued at $17,000, carries no set-aside designation and will be performed in Washington, DC. The contract is issued as a child order under FedEx's parent entity, Fedex Corp, which holds a significant Indefinite Delivery/Indefinite Quantity contract...
- The Drug Enforcement Administration awarded a delivery order to Federal Express Corporation (FedEx) valued at $9,500 with a firm fixed-price structure and an ultimate completion date of September 30, 2026. This delivery order, issued on October 1, 2025, requires courier and delivery services to be performed in Washington, DC. The award carries no set-aside designation, indicating FedEx competed on a full and open basis. This delivery order is issued under the Next Generation Delivery Services...
- The Drug Enforcement Administration awarded a delivery order valued at $24,904.39 to Federal Express Corporation (FedEx) for overnight mail service on October 1, 2024, with a period of performance through September 30, 2025. The contract, issued under reference number 15JPSS24D00000254, is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Services will be performed in Washington, DC. This delivery order is issued under FedEx's broader Next...
- The Drug Enforcement Administration (DEA) awarded a delivery order valued at $8,000 to Federal Express Corporation (FedEx) on October 1, 2025, for a one-year performance period ending September 30, 2026. This firm-fixed-price delivery order carries no set-aside designation, indicating full and open competition. The contract is issued under FedEx's Next Generation Delivery Services 2 (NGDS 2) Indefinite Delivery/Indefinite Quantity (IDIQ) vehicle, which provides federal agencies with access to...
- Federal Express Corporation (FedEx) was awarded a delivery order valued at $11,000 by the Drug Enforcement Administration for small package shipping services to the Washington, DC area. The contract, issued on October 1, 2025, under reference number 15JPSS25D00000293, is structured as a firm fixed-price delivery order with a performance period extending through September 30, 2026. This award was made without a set-aside designation, indicating that FedEx competed on a full and open basis. The...
- The Drug Enforcement Administration awarded a delivery order to Federal Express Corporation (FedEx) on October 1, 2025, for mail delivery services at its Chantilly, Virginia facility through September 30, 2026. This $5,000 firm-fixed-price contract operates under the Next Generation Delivery Services 2 (NGDS 2) Indefinite Delivery/Indefinite Quantity vehicle, a Department of Defense-administered IDIQ contract that enables federal agencies to procure comprehensive shipping and logistics...
- The Drug Enforcement Administration awarded a delivery order valued at $12,000 to Federal Express Corporation for express and ground shipping services to support mission-essential operations. This order was placed against the Department of Justice's mandatory Blanket Purchase Agreement with FedEx and carries a firm fixed-price structure with no set-aside designation. The contract is scheduled for completion by September 30, 2026, with performance taking place in Washington, DC. This delivery...
- The Drug Enforcement Administration awarded a delivery order to Federal Express Corporation (FedEx) on October 1, 2025, for express delivery services with a ceiling value of $15,750. This firm fixed-price contract, which contains no set-aside designation, represents a competitive award issued under the Next Generation Delivery Services 2 (NGDS 2) Indefinite Delivery/Indefinite Quantity vehicle administered by the Department of Defense. The contract is set to conclude on September 30, 2026,...